Interferon alpha-induced modulation of leukocyte cell surface antigens: immunocytofluorometric study with human

B Chorváth1, J Sedlák, N Fuchsberger

  • 1Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Czechoslovakia.

Acta Virologica
|January 1, 1991
PubMed

Insights

Recombinant interferon alpha increases MHC class I antigen density on leukemia and lymphoma cell lines. However, it did not significantly alter other key cell surface markers like CD45 or CD71.

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • Interferons are crucial in immune response and cellular regulation.
  • Understanding interferon's effects on cancer cell surface antigens is vital for therapeutic development.
  • Leukemia and lymphoma cell lines serve as models for studying these interactions.

Purpose of the Study:

  • To investigate the impact of recombinant interferon alpha on the expression of major histocompatibility complex (MHC) class I antigens.
  • To evaluate the effects of interferon alpha on other cell surface markers in human leukemia and lymphoma cell lines.
  • To compare the effects of recombinant interferon alpha with human leukocyte interferon alpha.

Main Methods:

  • Utilized immunocytofluorometry with specific monoclonal antibodies.
  • Analyzed human leukemia/lymphoma cell lines (REH, U-937, HL-60, K-562).
  • Assessed expression of MHC class I, MHC class II, CD45, CD71, CD10, and CD4 antigens.

Main Results:

  • Recombinant interferon alpha significantly enhanced MHC class I antigen density on REH, U-937, and HL-60 cells.
  • Human leukocyte interferon alpha showed a similar effect on MHC class I in REH cells.
  • No major alterations in CD45 or CD71 expression were observed; CD10 remained unchanged in REH cells. CD4 density decreased on U-937 cells. K-562 cells showed no induction of MHC antigens.

Conclusions:

  • Interferon alpha effectively upregulates MHC class I antigens on specific leukemia/lymphoma cell lines.
  • The effects on other cell surface markers are variable and cell-type dependent.
  • These findings contribute to understanding interferon's immunomodulatory role in hematological malignancies.

Related Concept Videos